Just a moment, the page is loading...
The GSK Supported Studies Portal is being upgraded and will be unavailable from Wednesday 27th of January at 5.00PM EST to Tuesday 2nd of February 7.00am EST . If you are anticipating submitting a proposal during this time please submit once the new system is live on the 2nd of February. During this time please contact your Country Medical Point of Contact for any queries. We apologise for any inconvenience.
The Supported Studies Programme
For the latest updates on GSK’s response to COVID-19, please click here.



Proposal submission period is currently closed and the date for Cycle 3 is to be confirmed. In response to COVID-19 GSK is closely monitoring the pandemic and is supporting global efforts. To read about GSKs actions to support the global response to COVID-19 please click here. Should you have any queries or if you want to discuss a concept please contact your Local Medical Point of contact.

For detail about the timelines and Respiratory Areas of Interest with Salmeterol plus fluticasone, fluticasone and salbutamol products, please refer to the Classic & Established (Marketed) page

Although GSK are more likely to support studies aligned to our current areas of interest for supported studies, we are interested in supporting studies that are innovative and contribute to scientific knowledge relating to a product, a medical condition or advancing a technology.

© 2001-2021 GlaxoSmithKline plc. All rights reserved. Registered in England and Wales No. 3888792.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.